RAPS-National University of Singapore Certificate Program Celebrates First Graduating Class
Posted 14 October 2015 | By
The Medical Device Regulatory Affairs (MDRA) Graduate Certificate Program, a joint academic program from RAPS and the School of Biomedical Engineering at the National University of Singapore (NUS), graduated its first cohort of 31 students last month. The program was developed in partnership with several of Singapore’s government agencies as part of the country’s efforts to nurture a highly competent regulatory workforce.
Singapore has spent much of the past decade positioning itself to attract regional and global biopharma and medical technology companies to establish presences there. As a result, it has grown to become a major hub for life sciences and medicine. Recognizing the need to support the growing life sciences sector, Singapore’s government has invested in infrastructure and workforce development—including, critically, the regulatory workforce.
Raymond Chua, group director of the Health Products Regulation Group of Singapore’s Health Sciences Authority addressed the class during its recent graduation ceremony. Chua also is co-chair of RAPS’ Pan-Asian advisory committee and a member of the MDRA program advisory committee. “RAPS looks forward to each of you becoming active regulatory professionals and leaders each in your own way committed to regulatory excellence within the regulatory ecosystem in Asia, be it whether you are in the industry or a regulator or in the academic field,” said Chua. He also congratulated graduates on what he called a “stellar achievement.”
Graduates of the first RAPS-NUS MDRA program are:
- Cha Yuen Woon, regional QA/RA manager (ASEAN), bioMerieux Singapore Pte. Ltd.
- Chan Shiyu Jasmine, regulatory affairs specialist, Hill-Rom Services
- Cheah Pei Shi, regulatory affairs executive, Terumo Singapore Pte. Ltd.
- Foo Yong Jie Charlton, regulatory affairs support, GE Healthcare Pte. Ltd.
- Gan Siow Boon, associate regulatory affairs specialist, Medtronic Singapore Operations Pte. Ltd.
- Koh Kah Leng, regulatory specialist, Health Sciences Authority
- Kwok Ka Po (Melody), regulatory and quality consultant, ARQon Pte. Ltd.
- Lai David Tien Min, clinical director of MERCI, director of surgical research and development, senior research fellow, National University of Singapore
- Law Liong Hwee, validation engineer, Illumina Singapore Pte. Ltd.
- Lee Jun Jie Stanley, regulatory affairs executive, Olympus Singapore Pte. Ltd.
- Lee Li Mei, associate director, Illumina Singapore Pte. Ltd.
- Ler Kian Seng, quality assurance, Cardinal Health Singapore
- Lim Puay Chee, senior LCM engineer, Illumina Singapore Pte. Ltd.
- Low Lai Peng, senior regulatory specialist, Health Sciences Authority
- Mao Yi Qing, RA manager, ASEAN, GE Healthcare
- Meah Wee Chong, regulatory affairs manager, Grifols Asia Pacific Pte Ltd
- Top 3 Students - Bronze Award Recipient
- Ng Boon Yee, associate regulatory affairs specialist, Medtronic International Limited
- Oh Say Wei, senior validation engineer, Illumina Singapore Pte. Ltd.
- Tan Chee Chong, section head, Siemens Medical Instruments Pte. Ltd.
- Tan Kwan Ling, research engineer, Institute of Microelectronics, A*STAR
- Tan Yuhua, senior regulatory specialist, Health Sciences Authority
- Tay Yan Bing Crispina, regional technologist (external innovation acquisition), Asiapac, Boston Scientific
- Teo Siow Thing, quality engineer, EndoMaster Pte Ltd
- Teoh Yu-Lin Denise, assistant head, IPO, A*STAR/Biomedical Sciences Institute
- Toh Yanling, project engineer, A*STAR Science and Engineering Institutes
- Viryanti, regulatory affairs manager, Advanced First Aid Research Pte. Ltd.
- Wong Chee Hoo, regulatory affairs manager, ASEAN, DH RegSys Pte. Ltd.
- Wong Ray Chong Alexander, senior officer, A*STAR/BMRC/MEDTECH
- Wong Wah Jie, regulatory analyst, Thermo Fisher Scientific
- Wong Wee Zee, staff engineer, Illumina Singapore Pte. Ltd.
- Yoh Soh Zeom, senior regulatory specialist, Health Sciences Authority
Lee Jun Jie Stanley, Teoh Yu-Lin Denise and Meah Wee Chong were
recognized as the top three students in the class.
The MDRA program’s second cohort recently began its course of study. For more information about the program, visit NUS’s MDRA program page.
Related ArticlesMDRA Faculty Discuss Importance of Regulatory Knowledge, Goals of Program
RAPS, National University of Singapore Gear up for 2nd Year of Certificate Program